Western Pacific Wealth Management LP purchased a new stake in Baxter International Inc. (NYSE:BAX – Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 3,000 shares of the medical instruments supplier’s stock, valued at approximately $114,000.
A number of other hedge funds and other institutional investors also recently made changes to their positions in BAX. Bank of New York Mellon Corp grew its holdings in Baxter International by 73.2% during the 2nd quarter. Bank of New York Mellon Corp now owns 6,772,533 shares of the medical instruments supplier’s stock valued at $226,541,000 after buying an additional 2,862,626 shares in the last quarter. LSV Asset Management bought a new position in Baxter International during the second quarter valued at approximately $140,296,000. Shapiro Capital Management LLC raised its position in Baxter International by 19.7% in the 2nd quarter. Shapiro Capital Management LLC now owns 3,285,048 shares of the medical instruments supplier’s stock worth $109,885,000 after purchasing an additional 541,575 shares during the period. Thompson Siegel & Walmsley LLC bought a new stake in Baxter International in the second quarter worth $67,263,000. Finally, Coho Partners Ltd. purchased a new stake in Baxter International during the third quarter valued at about $57,229,000. 90.19% of the stock is currently owned by institutional investors.
Baxter International Stock Down 0.2 %
NYSE:BAX opened at $36.04 on Friday. The company has a debt-to-equity ratio of 1.35, a current ratio of 1.40 and a quick ratio of 0.91. The firm’s 50-day moving average price is $37.50 and its 200-day moving average price is $36.16. The company has a market capitalization of $18.39 billion, a PE ratio of 7.42, a P/E/G ratio of 1.21 and a beta of 0.60. Baxter International Inc. has a 1-year low of $32.48 and a 1-year high of $44.01.
Analyst Upgrades and Downgrades
Several equities research analysts recently weighed in on the company. StockNews.com upgraded Baxter International from a “hold” rating to a “buy” rating in a report on Tuesday, October 22nd. Citigroup lifted their target price on shares of Baxter International from $38.00 to $40.00 and gave the stock a “neutral” rating in a research note on Tuesday, October 1st. The Goldman Sachs Group increased their price target on shares of Baxter International from $36.00 to $40.00 and gave the company a “neutral” rating in a research report on Thursday, August 8th. Wells Fargo & Company decreased their price objective on shares of Baxter International from $44.00 to $40.00 and set an “equal weight” rating on the stock in a research report on Wednesday, August 7th. Finally, Morgan Stanley downgraded shares of Baxter International from an “equal weight” rating to an “underweight” rating and lowered their price objective for the company from $39.00 to $30.00 in a research note on Monday, July 15th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $41.20.
Read Our Latest Research Report on BAX
About Baxter International
Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.
Read More
- Five stocks we like better than Baxter International
- What Is WallStreetBets and What Stocks Are They Targeting?
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- How to Invest in the Best Canadian Stocks
- Breakout Alert: Qualcomm Just Hit The Rally Button
- Insider Buying Explained: What Investors Need to Know
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Want to see what other hedge funds are holding BAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Baxter International Inc. (NYSE:BAX – Free Report).
Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.